Skip to main content

Table 4 Risk Factor for Death Censored Graft Failure

From: Prediction of clinical outcomes after kidney transplantation from deceased donors with acute kidney injury: a comparison of the KDIGO and AKIN criteria

 

Univariate

Multivariate

Odd ratio (95% CI)

P value

Odd ratio (95% CI)

P value

Donor

    

 Age

1.00 (0.97-1.03)

0.9

  

 Male

1.15 (0.42-3.11)

0.8

  

 BMI

0.89 (0.75-1.06)

0.2

  

 DM

0.77 (0.09-6.06)

0.8

  

 Hypertension

2.21 (0.80-6.11)

0.1

  

 Cause of death (CVA)

1.88 (0.66-5.39)

0.2

  

 AKI by KDIGO

0.98 (0.32-3.01)

0.9

1.37 (0.19-10.09)

0.8

 AKI by AKIN

0.44 (0.13-1.45)

0.2

0.18 (0.02-1.40)

0.1

 CVP

1.02 (0.89-1.16)

0.1

  

MAP

0.97 (0.94-1.01)

0.8

  

 Last day urine output

1.00 (1.00-1.00)

0.4

  

 Cold ischemic time

1.00 (0.99-1.00)

0.4

  

Recipient

    

 Age

0.97 (0.92-1.02)

0.2

  

 Male

1.15 (0.45-2.94)

0.8

  

 BMI

0.83 (0.70-0.99)

0.03

0.57 (0.41-0.80)

0.002

 DM

0.55 (0.12-2.45)

0.4

  

 Hypertension

1.29 (0.29-5.82)

0.7

  

 GN

1.45 (0.57-3.68)

0.4

  

 Retransplantation

1.04 (0.23-4.75)

0.9

  

 PRA

0.96 (0.91-1.02)

0.2

  

 HLA MN

1.64 (1.03-2.62)

0.04

  

 ATG (Reference = Basiliximab)

0.71 (0.16-3.18)

0.6

  

 Tacrolimus (Reference = Cyclosporine)

0.40 (0.14-1.21)

0.1

  

 Delayed graft function

1.95 (0.71-5.37)

0.2

9.25 (1.93-44.33)

0.005

 Acute rejection

7.55 (2.86-19.91)

<0.001

6.00 (1.06-34.09)

0.04

  1. Abbreviations: CI confidence interval, BMI body mass index, DM diabetes mellitus, CVA cerebrovascular accident, KDIGO kidney disease: improving global outcome, AKIN acute kidney injury network, CVP central venous pressure, MAP mean arterial pressure, GN glomerulonephritis, PRA panel reactive antibody HLA human leukocyte antigen, MN mismatch number, ATG anti-thymocyte globulin